Src activation is not necessary for transforming growth factor (TGF)-β-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells

PP1 directly inhibits TGF-β receptors I and II

Masato Maeda, Yasushi Shintani, Margaret J. Wheelock, Keith R Johnson

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Epithelial to mesenchymal transitions (EMTs) are key events during embryonic development and cancer progression. It has been proposed that Src plays a major role in some EMT models, as shown by the overexpression of viral Src (v-Src) in epithelial cells. It is clear that Src family kinases can regulate the integrity of both adherens junctions and focal adhesions; however, their significance in EMT, especially in the physiological context, remains to be elucidated. Here we showed that Src is activated in transforming growth factor-β1 (TGF-β1)-mediated EMT in mammary epithelial cells and that the Src family kinase inhibitor, PP1, prevents EMT. However, neither a more specific Src family kinase inhibitor, SU6656, nor a dominant-negative Src inhibited TGF-β1-mediated EMT, leading us to speculate that Src activation is not an essential component of TGF-β1-mediated EMT. Unexpectedly, PP1 prevented Smad2/3 activation by TGF-β1, whereas SU6656 did not. Most interestingly, an in vitro kinase assay showed that PP1 strongly inhibited the TGF-β receptor type I, and to a lesser extent, the TGF-β receptor type II. Taken together, our data indicated that PP1 interferes with TGF-β1-mediated EMT not by inhibiting Src family kinases but by inhibiting the Smad pathway via a direct inhibition of TGF-β receptor kinase activity.

Original languageEnglish (US)
Pages (from-to)59-68
Number of pages10
JournalJournal of Biological Chemistry
Volume281
Issue number1
DOIs
StatePublished - Jan 6 2006

Fingerprint

Epithelial-Mesenchymal Transition
Growth Factor Receptors
Transforming Growth Factors
Breast
Epithelial Cells
Chemical activation
src-Family Kinases
Phosphotransferases
Adherens Junctions
Focal Adhesions
Embryonic Development
Assays
Adhesion

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

@article{40fa4266c8ab4ea9a9dac6c544252f28,
title = "Src activation is not necessary for transforming growth factor (TGF)-β-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells: PP1 directly inhibits TGF-β receptors I and II",
abstract = "Epithelial to mesenchymal transitions (EMTs) are key events during embryonic development and cancer progression. It has been proposed that Src plays a major role in some EMT models, as shown by the overexpression of viral Src (v-Src) in epithelial cells. It is clear that Src family kinases can regulate the integrity of both adherens junctions and focal adhesions; however, their significance in EMT, especially in the physiological context, remains to be elucidated. Here we showed that Src is activated in transforming growth factor-β1 (TGF-β1)-mediated EMT in mammary epithelial cells and that the Src family kinase inhibitor, PP1, prevents EMT. However, neither a more specific Src family kinase inhibitor, SU6656, nor a dominant-negative Src inhibited TGF-β1-mediated EMT, leading us to speculate that Src activation is not an essential component of TGF-β1-mediated EMT. Unexpectedly, PP1 prevented Smad2/3 activation by TGF-β1, whereas SU6656 did not. Most interestingly, an in vitro kinase assay showed that PP1 strongly inhibited the TGF-β receptor type I, and to a lesser extent, the TGF-β receptor type II. Taken together, our data indicated that PP1 interferes with TGF-β1-mediated EMT not by inhibiting Src family kinases but by inhibiting the Smad pathway via a direct inhibition of TGF-β receptor kinase activity.",
author = "Masato Maeda and Yasushi Shintani and Wheelock, {Margaret J.} and Johnson, {Keith R}",
year = "2006",
month = "1",
day = "6",
doi = "10.1074/jbc.M503304200",
language = "English (US)",
volume = "281",
pages = "59--68",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "1",

}

TY - JOUR

T1 - Src activation is not necessary for transforming growth factor (TGF)-β-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells

T2 - PP1 directly inhibits TGF-β receptors I and II

AU - Maeda, Masato

AU - Shintani, Yasushi

AU - Wheelock, Margaret J.

AU - Johnson, Keith R

PY - 2006/1/6

Y1 - 2006/1/6

N2 - Epithelial to mesenchymal transitions (EMTs) are key events during embryonic development and cancer progression. It has been proposed that Src plays a major role in some EMT models, as shown by the overexpression of viral Src (v-Src) in epithelial cells. It is clear that Src family kinases can regulate the integrity of both adherens junctions and focal adhesions; however, their significance in EMT, especially in the physiological context, remains to be elucidated. Here we showed that Src is activated in transforming growth factor-β1 (TGF-β1)-mediated EMT in mammary epithelial cells and that the Src family kinase inhibitor, PP1, prevents EMT. However, neither a more specific Src family kinase inhibitor, SU6656, nor a dominant-negative Src inhibited TGF-β1-mediated EMT, leading us to speculate that Src activation is not an essential component of TGF-β1-mediated EMT. Unexpectedly, PP1 prevented Smad2/3 activation by TGF-β1, whereas SU6656 did not. Most interestingly, an in vitro kinase assay showed that PP1 strongly inhibited the TGF-β receptor type I, and to a lesser extent, the TGF-β receptor type II. Taken together, our data indicated that PP1 interferes with TGF-β1-mediated EMT not by inhibiting Src family kinases but by inhibiting the Smad pathway via a direct inhibition of TGF-β receptor kinase activity.

AB - Epithelial to mesenchymal transitions (EMTs) are key events during embryonic development and cancer progression. It has been proposed that Src plays a major role in some EMT models, as shown by the overexpression of viral Src (v-Src) in epithelial cells. It is clear that Src family kinases can regulate the integrity of both adherens junctions and focal adhesions; however, their significance in EMT, especially in the physiological context, remains to be elucidated. Here we showed that Src is activated in transforming growth factor-β1 (TGF-β1)-mediated EMT in mammary epithelial cells and that the Src family kinase inhibitor, PP1, prevents EMT. However, neither a more specific Src family kinase inhibitor, SU6656, nor a dominant-negative Src inhibited TGF-β1-mediated EMT, leading us to speculate that Src activation is not an essential component of TGF-β1-mediated EMT. Unexpectedly, PP1 prevented Smad2/3 activation by TGF-β1, whereas SU6656 did not. Most interestingly, an in vitro kinase assay showed that PP1 strongly inhibited the TGF-β receptor type I, and to a lesser extent, the TGF-β receptor type II. Taken together, our data indicated that PP1 interferes with TGF-β1-mediated EMT not by inhibiting Src family kinases but by inhibiting the Smad pathway via a direct inhibition of TGF-β receptor kinase activity.

UR - http://www.scopus.com/inward/record.url?scp=33644849647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644849647&partnerID=8YFLogxK

U2 - 10.1074/jbc.M503304200

DO - 10.1074/jbc.M503304200

M3 - Article

VL - 281

SP - 59

EP - 68

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 1

ER -